Media Mentions
Phoenix nurse who helped fight New York’s COVID-19 surge now battling brain cancer
The Arizona Republic shares the story of Ian Youngblood, a 29-year-old nurse from Arizona who received a harrowing diagnosis of glioblastoma while helping fight COVID-19 on the frontlines in NYC. Dr. Nader Sanai weighs in on why these types of tumors are so hard to control and what it will take to move the needle on identifying new, effective treatment options.
Nurse who fought coronavirus in New York now battles his own brain cancer
Ian's story has moved the country for his strength and selfless service on the COVID-19 frontlines in NYC. Now, facing a battle of his own, he's turning to Dr. Nader Sanai and his team at the Ivy Brain Tumor Center and Barrow Neurological Institute to help him fight one of the most aggressive forms of brain cancer, glioblastoma.
Woman of the Week Podcast: Catherine Ivy
Catherine Ivy, who lost her husband a decade ago to a devastating and sudden brain cancer, shares her personal journey of grief and purpose, which led to the founding of the Ivy Brain Tumor Center at the Barrow Neurological Institute.
Cancer Today Magazine cover story features Lanette Veres of the Gray Matters Foundation
Brain cancer survivor Lanette Veres sends cards and packages to others with the disease. She believes no one should face cancer alone.
Philanthropist Funds Personalized Research Program For Brain Cancer
Catherine Ivy sat down with Devin Thorpe's Your Mark On The World to discuss her personal fight with glioblastoma and how she hopes to shake up the research process with her investment in the Ivy Center's Phase 0 clinical trials.
Social Impact Heroes: “Why Catherine Ivy and the Ivy Foundation have contributed over $91 million to accelerate drug and treatment discovery for brain cancer”
Catherine Ivy was recently interviewed for Authority Magazine's latest "Social Impact Heroes" series where she opened up about her 14-year journey to accelerate drug discovery for brain tumor patients, a recent success story from the Ivy Center's Phase 0 clinical trials program, and what our community, society and politicians can do to help address the unmet needs of patients battling aggressive brain tumors.
The Ivy Brain Tumor Center Identifies New Breast Cancer Drug as Possible Glioblastoma Therapy
The Ivy Brain Tumor Center at the Barrow Neurological Institute recently completed a Phase 0 clinical trial of the breast cancer drug ribociclib (Kisqali) for the treatment of recurrent glioblastoma. The Ivy recently received $50 million to combat brain cancer. This new drug cocktail represents one of the potential weapons in humankind’s war against this killer disease.
By Targeting Each Patient’s Unique Tumor, Precision Medicine Is Crushing Once-Untreatable Cancers.
Newsweek's cover story examines the rising success of precision medicine to fight once-untreatable tumors and highlights our efforts in using this method to fight glioblastoma where speed and personalization are key.
Could Karyopharm’s Newly Approved Multiple Myeloma Drug Also Work In Glioblastoma?
The Ivy Brain Tumor’s goal is to try to speed advances into the clinic by testing potential therapies on tumor samples taken from patients who are currently battling glioblastoma—an approach its researchers hope will shed some light on the potential of Karyopharm’s new drug in treating the disease.
The Ivy Brain Tumor Center Takes A ‘High Risk, High Reward’ Approach To Brain Cancer Trials
"Our philosophy is that it is as important to fail fast as it is to succeed quickly," said Nader Sanai, the director of the Ivy Brain Tumor Center at Barrow Neurological Institute.